We designed CRISPR/Cas9 gRNAs against two key ciliogenesis genes, KIF3A and ARL13B. KIF3A is an anterograde motor subunit, without which glioma cilia fail to normally assemble [25,34]. Here, ARL13B is linked to central nervous system cancer.